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Background: Hyaluronic acid fillers are known for a reliable safety profile, but com-
plications do occur, even serious vascular adverse events.
Objective: To improve the safety of hyaluronic acid filler treatments.
Methods: Ultrasound is used to image hyaluronic acid fillers.
Results: Before a filler treatment is performed with ultrasound, previous filler treat-
ments can be brought in to sight and vascular mapping can be performed. In case of
adverse events, the filler and the surrounding tissues are visible. Dislocation,
abscesses, and vascular adverse events can be seen. Under ultrasound guidance,
hyaluronidase can be injected directly into the filler deposit.
Conclusion: Ultrasound examination can be an important tool to improve the safety
of hyaluronic acid filler treatments.
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1 | INTRODUCTION
Cosmetic medicine is a continuously growing field, including mini-
mally invasive treatments with resorbable dermal fillers. Hyaluronic
acid fillers are the most commonly used products. According to the
American Society of Aesthetic Plastic Surgery, over 2.4 million treat-
ments were performed with hyaluronic acid fillers in 2016.1
As most patients treated are healthy people looking for a cos-
metic improvement, the treatments performed should be as safe
as possible. Although these fillers are known for a reliable safety
profile, adverse events do occur.2,3 Complications can be caused
by the product itself (too strong cross‐linking of the product),
the product‐host interaction (allergic reactions, inflammatory
responses), or the injection technique performed (accumulation or
dislocation of the product due to muscle movement, intravascular
injection, or vascular compression of filler material).3,4 In its most
serious form, intravascular injection or vascular compression of
filler material can lead to skin necrosis or, in rare cases, blind-
ness.5,6 It has been suggested that the minor signs of vascular
compression may be misinterpreted as injection‐related bruising,
pain, and swelling.7
Guidelines and other articles focused on hyaluronic acid fillers
are published in order to minimize potential damage to skin and
underlying tissue.8–11
Hyaluronic acid fillers come with the advantage of being dissolv-
able with hyaluronidase in case of complications.12 If this is neces-
sary, identifying the location of the filler in the skin is important as
hyaluronidase should be injected into the filler mass. However, when
the filler is placed deep dermally, detection can be very difficult.
Doppler ultrasound (duplex) is commonly used in dermatology to
evaluate dermatological conditions of the skin and vascular structures,
13,14 specifically in the diagnosis of venous disease of the lower leg.
Yet, it can also help to improve the safety of hyaluronic acid filler
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injections in two distinct ways. First, it is possible to identify the filler in
case of a complication.15,16 Second, prevention of complications will be
improved by locating the important vascular structures and earlier filler
treatments in the projected area before a new treatment is performed.
2 | ULTRASOUND FOR FILLERS
An ultrasound device consists of a probe and a processor. The probe
will generate a sound wave that penetrates body tissue. Sound
waves interact with the tissue and become progressively weaker in
strength as the waves are absorbed or scattered. Part of the sound
waves is being reflected. The reflected sound waves, picked up by
the probe and directed to the processor, are transformed into a digi-
tal image. Based on echogenicity Table 1, a filler, or its reaction in
tissue, will be imaged as hyperechoic (white on the screen), hypoe-
choic (gray on the screen), and anechoic (black on the screen). Tis-
sues are isoechogenic if they show the same echogenicity as the
neighboring tissue, which makes these two tissues indistinguish-
able.17
When a Doppler system is integrated with the ultrasound, the
device is named duplex. With a duplex machine, blood flow is made
visible on the screen in red and blue colors. Herewith, blood vessels
can be identified in conjunction with other dermal structures.
Fillers come in different formulae, but they have hydrophilic or
hydrophobic characteristics.
All hyaluronic acid fillers are able to bind water and are thus
hydrophilic. As water content does not reflect the sound waves, hya-
luronic acid appears black (an echogenic) or light gray hypoechoic)
on ultrasound Figure 1.18 The ubiquitously used hyaluronic acid fil-
lers come in different particle sizes, meant for different applications,
and are placed in different layers of the skin and subdermis.
Depending on the technique, a treading line of multiple dark depos-
its can be seen, specifically when a cannula is used Figure 1 or a
large dark deposit bolus injections for volume replacement) may be
visible Figure 2.
3 | ULTRASOUND TO IMPROVE THE
SAFETY OF HYALURONIC ACID FILLER
TREATMENTS
At our ambulant cosmetic university hospital clinic, we routinely use
ultrasound examination to minimize risks, but also to locate and
identify fillers in patients with side effects who are referred to us.
With ultrasound/duplex examination, skin, the underlying tissue
including muscles, veins, and arteries can be made visible. At the
same time, any filler can be brought into sight, measured in pocket
size, and the plane of injection can be seen. We experience that the
use of duplex provides an important improvement in the safety of
dermal filler treatments.
3.1 | Previous filler treatments
Not only hyaluronic acid but also all fillers are visible with ultra-
sound.15,19 Patients who had previous filler treatments may not
always remember the type of filler and the place and plane of injec-
tion. Yet, different filler substances may give unwanted side effects,
TABLE 1 Grayscale of echogenicity
Echogenicity The ability of a tissue or substance to reflect sound
waves and produce echoes
Anechoic No echoes, appears black on ultrasound
Hypoechoic Less reflective and lower amount of echoes, appears as
varying shades of dark gray
Hyperechoic Highly reflective and echo‐rich when compared to
neighboring structures, appears as varying shades of
light gray
Isoechoic Having similar echogenicity to a neighboring structure
F IGURE 1 Multiple deposits of hyaluronic acid filler, two
anechoic deposits (black)and one hypoechoic deposit*
F IGURE 2 Oval‐shaped hypoechoic single deposit of hyaluronic
acid
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when mixed. Figure 3 shows the lower face of a 61‐year‐old woman.
She was previously injected with polymethylmethacrylate (PMMA).
After a hyaluronic acid filler was injected in the corners of the
mouth, she developed an inflammatory response of polymethyl-
methacrylate (PMMA). The upper lip and chin were also responding
with an inflammatory response, although not treated with hyaluronic
acid. Using ultrasound before a filler treatment can help to distin-
guish between the different types of fillers used previously and thus
to avoid complications Figure 4.
3.2 | Anatomical mapping
Serious complications of filler treatments are intravascular injection
or vascular compression of filler material leading to skin necrosis or,
in rare cases, blindness. As these vessels are not visible clinically,
prevention is extremely important. Guidelines advise to use an
F IGURE 3 Inflammatory response of polymethylmethacrylate
after hyaluronic acid filler is injected in the corners of the mouth.
Note: the upper lip and chin are also responding
F IGURE 4 Polymethylmethacrylate visible with ultrasound
F IGURE 5 Locating artery with duplex
F IGURE 6 Longitudinal view of corresponding artery
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adequate injection technique such as cannulas and to inject
slowly.11,20,21 Most of all, anatomical knowledge of the face and the
course of veins and arteries is crucial. Unfortunately, individual varia-
tions in facial artery anatomy may exist.22,23 Ultrasound allows visu-
alization of the facial arteries and veins of the proposed treatment
area and is a noninvasive imaging tool for vascular mapping before
the treatment is started.
Vascular structures appear anechoic black, containing liquid) and
linear when the transducer is in the same line as the vessel, or circu-
lar when the transducer is placed on a section of the vessel. Duplex
sonography B‐scan ultrasound combined with color Doppler ultra-
sound) helps to distinguish structures with movement, for example
blood moving within vessels. Color Doppler blue vs red) can also be
used to determine the direction of the blood flow when needed Fig-
ures 5 and 6.
3.3 | Treatment of adverse events with ultrasound
Recently publicized protocols and guidelines describe how to treat
unwanted adverse events.24 In our experience, dissolving the filler
will terminate most of the adverse events. As mentioned above, hya-
luronic acid fillers are easily seen with ultrasound. The pocket size
and the location of the filler can be brought into sight. Under ultra-
sound guidance, hyaluronidase can be injected directly into the filler
pocket causing the adverse event Figure 7.
Dislocation, overcorrection of product, and vascular adverse
events can be treated in this way to eliminate the cause of the prob-
lem. In case of an inflammatory response, temporary medication as
antibiotic treatment may be needed as adjuvant treatment. Special
attention is given to vascular adverse events as intravascular injec-
tion of filler material or vascular compression Figure 8 may lead to
severe complications as necrosis. The use of ultrasound is very help-
ful in the treatment of these complications and in the treatment out-
come. In Figure 9, the beginning of crusting as a result of a vascular
adverse event is seen. This was due to a hyaluronic acid filler treat-
ment in the right lower lip to obtain a lip augmentation. The
F IGURE 7 Under ultrasound guidance the needle is inserted in
the filler deposit top right
F IGURE 8 Vascular adverse event, hyaluronic acid filler deposit
compromises vessel
F IGURE 9 Crusting on under lip
F IGURE 10 Healing of the under lip, no scarring
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referring physician described pain and blanching during injection.
Hyaluronidase (150U) was injected once under ultrasound guidance
in the hypoechogenic deposit. Immediate improvement was noted
by the patient, continuing throughout the day, with complete recov-
ery of her lip Figure 10.
4 | CONCLUSION
Ultrasound examination can be an important tool to improve the
safety of hyaluronic acid filler treatments. The amount, location, and
depth of the injected hyaluronic acid fillers can be identified. With
some practice, it makes a precise intralesional delivery of hyaluroni-
dase possible. As prevention, duplex ultrasound can be used to iden-
tify vascular structures in the proposed treatment areas Figure 11.
The learning curve to use and interpret duplex ultrasound pic-
tures is, in our experience, not too steep. Small probes with direct
connections to tablets are becoming more and more available for
reasonable prices. We feel that these devices should be available in
any office of a doctor using hyaluronic acid‐based fillers.
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